Cargando…
Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report
BACKGROUND: Immune checkpoint inhibitors (ICIs) are increasingly being used in the treatment of several cancers. Pembrolizumab is an anti-programmed cell death-1 (anti-PD-1) monoclonal antibody that is approved for the treatment of metastatic non-small cell lung cancer (NSCLC). Pembrolizumab-associa...
Autores principales: | Yang, Zhi, Xu, Huan, Gou, Shenju, Wu, Hongyan, Hu, Zhangxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210450/ https://www.ncbi.nlm.nih.gov/pubmed/37226096 http://dx.doi.org/10.1186/s12882-023-03202-5 |
Ejemplares similares
-
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report
por: El Yamani, Nidal, et al.
Publicado: (2023) -
What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?
por: Xiao, Xiang, et al.
Publicado: (2022) -
Glomerulonephritis with Crescents in Polyomavirus Nephropathy
por: Sekar, Aravind, et al.
Publicado: (2022) -
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T > C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy
por: Wu, Hongyan, et al.
Publicado: (2018) -
Hemoglobin Cast Nephropathy
por: Mahmud, Saqib, et al.
Publicado: (2020)